Tadeusz Laudanski

Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug

T. Laudański, A. Breeze, M. Åkerlund, 2004, Cancer Chemotherapy and Pharmacology.

Fibromyomas and uterine contractions

T. Laudański, J. Szamatowicz, M. Åkerlund, 1997, Acta obstetricia et gynecologica Scandinavica.

Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances

M. Åkerlund, Tadeusz Laudanski, Thomas Bossmar, 1998, Acta Obstetricia et Gynecologica Scandinavica.